S03350 - Requires practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry.
New York - 2023-2024 General Assembly
Introduced byNathalia Fernandez
Last updated over 1 year ago
1 Co-Sponsor
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now